Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial
- Resource Type
- Article
- Authors
- Kintu, Kenneth; Malaba, Thokozile R; Nakibuka, Jesca; Papamichael, Christiana; Colbers, Angela; Byrne, Kelly; Seden, Kay; Hodel, Eva Maria; Chen, Tao; Twimukye, Adelline; Byamugisha, Josaphat; Reynolds, Helen; Watson, Victoria; Burger, David; Wang, Duolao; Waitt, Catriona; Taegtmeyer, Miriam; Orrell, Catherine; Lamorde, Mohammed; Myer, Landon; Khoo, Saye
- Source
- In The Lancet HIV May 2020 7(5):e332-e339
- Subject
- Primary Research
Articles
- Language
- ISSN
- 2352-3018